A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
HRYZ Biotech Co.
HRYZ Biotech Co.
Masonic Cancer Center, University of Minnesota
Samsung Medical Center
Samsung Medical Center
Masonic Cancer Center, University of Minnesota
Institut Claudius Regaud
Children's Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center